A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors

Clinical trial NCT04644315 · TERMINATED

Trial details

NCT number: NCT04644315
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms Colorectal Neoplasms Melanoma Pancreatic Neoplasms Sarcoma Ovarian Neoplasms Brain Neoplasms Thyroid Neoplasms Neuroendocrine Tumors Cholangiocarcinoma Salivary Gland Neoplasms Head and Neck Neoplasms

Start date: 2021-05-24
Primary completion: 2022-05-16
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.